Camille Donovan

Camille Donovan, MBA, is an experienced professional in program development and global program management, currently serving as Program Development Lead at REGENXBIO Inc. since September 2020, where responsibility includes leading a core interdisciplinary team in shaping strategic direction from pre-IND through to licensure for the company’s primary asset. Prior roles at GSK involved significant achievements, including managing technology transfers across global teams, leading successful regulatory filings that resulted in a product becoming a market leader, and implementing an agile team model for improved efficiency. Additional experience includes contributions at Amgen and Human Genome Sciences in manufacturing technology transfer and process development. Camille holds an MBA from UNC Kenan-Flagler Business School and a B.S. in Chemical Engineering from the University of Virginia.